The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease
NCT00250198
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
NIH
Sponsor class
Conditions
Crohn's Disease
Interventions
DRUG:
STA-5326
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)